Abstract / Summary
ABSTRACT We describe a rare case of suspected delayed‐onset TA‐TMA with ocular and neurological involvement following allo‐HSCT. The condition was refractory to standard therapies; neurological improvement was temporally associated with ruxolitinib initiation, suggesting a possible GVHD overlap. This report supports a multidisciplinary approach to complex post‐transplant endothelial injury and supports further investigation of JAK inhibition in selected cases.
Topics
allogeneic stem cell transplantationPurtscher‐like retinopathyruxolitinibtransplant associated thrombotic microangiopathyOpen access